The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject syringes. The health regulator said Alaris pumps are validated for use with Monoject syringes. However, the dimensions for Monoject syringes have recently changed while rebranding the syringes from Covidien Monoject to Cardinal Health Monoject.
The regulator's warning comes after Cardinal Health initiated a recall for its Monoject syringes due to incompatibility concerns with syringe pumps. Monoject syringes are used to inject into or withdraw fluids from the body while patient-controlled analgesia, or pain management pumps, are used to treat different kinds of pain by transferring medications intravenously.